Roflumilast – a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD. Swiss Med Wkly [Internet]. 2012 Jul. 15 [cited 2025 Dec. 1];142(2930):w13628. Available from: https://smw.ch/index.php/smw/article/view/1535